medmix AG (MEDX) — Cash Flow Reinvestment Rate
Latest as of December 2025:
0.50x
medmix AG (MEDX) has a Cash Flow Reinvestment Rate of 0.50x as of December 2025, reinvesting CHF18.80 Million (capex CHF18.80 Million ) from operating cash flow of CHF37.40 Million. See MEDX cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
0.50x
(Capex + Investments) / Operating CF
Total Reinvested
CHF18.80 Million
Capex + Investments
Operating Cash Flow
CHF37.40 Million
CHF
Capital Expenditures
CHF18.80 Million
CHF
medmix AG Cash Flow Reinvestment Rate (2018–2025)
Historical reinvestment intensity for medmix AG across 8 annual periods. For the full cash flow conversion analysis, see MEDX cash flow metrics.
Annual Cash Flow Reinvestment Rate for medmix AG (2018–2025)
Year-by-year capital reinvestment analysis for medmix AG. See medmix AG leverage flexibility ratio to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (CHF) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.51x | CHF34.50 Million | CHF67.80 Million | CHF34.50 Million | ▼ -55.9% |
| 2024 | 1.15x | CHF100.00 Million | CHF86.60 Million | CHF48.50 Million | ▼ -51.5% |
| 2023 | 2.38x | CHF133.50 Million | CHF56.10 Million | CHF52.90 Million | ▲ +18.5% |
| 2022 | 2.01x | CHF95.60 Million | CHF47.60 Million | CHF38.60 Million | ▲ +177.9% |
| 2021 | 0.72x | CHF63.10 Million | CHF87.30 Million | CHF31.90 Million | ▼ -57.8% |
| 2020 | 1.71x | CHF86.60 Million | CHF50.60 Million | CHF43.10 Million | ▲ +252.2% |
| 2019 | 0.49x | CHF43.30 Million | CHF89.10 Million | CHF36.20 Million | ▲ +23.4% |
| 2018 | 0.39x | CHF37.10 Million | CHF94.20 Million | CHF30.00 Million | — |
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow